| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CITIUS ONCOLOGY, INC. | Director | Stock Option (Right to Buy) | 125K | Dec 12, 2024 | Direct | ||
| Citius Pharmaceuticals, Inc. | Director | Stock Option (Right to Purchase Common Stock) | 125K | Nov 7, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CTOR | CITIUS ONCOLOGY, INC. | Dec 12, 2024 | 1 | $0 | 4 | Dec 16, 2024 | Director |
| CTXR | Citius Pharmaceuticals, Inc. | Nov 7, 2024 | 1 | $0 | 4 | Nov 12, 2024 | Director |
| CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 1 | $0 | 4 | Aug 14, 2024 | Director |
| CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director |
| CTXR | Citius Pharmaceuticals, Inc. | Oct 10, 2023 | 1 | $0 | 4 | Oct 12, 2023 | Director |
| CTXR | Citius Pharmaceuticals, Inc. | Oct 4, 2022 | 1 | $0 | 4 | Oct 6, 2022 | Director |
| CTXR | Citius Pharmaceuticals, Inc. | Oct 11, 2021 | 1 | $0 | 4 | Oct 13, 2021 | Director |
| CTXR | Citius Pharmaceuticals, Inc. | Jul 22, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Director |